Nanostructured lipid carrier-based codelivery of raloxifene and naringin: formulation, optimization, in vitro, ex vivo, in vivo assessment, and acute toxicity studies

HIGHLIGHTS

• who: Abdulsalam Alhalmi and colleagues from the Department of, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Flyde Road have published the article: Nanostructured Lipid Carrier-Based Codelivery of Raloxifene and Naringin: Formulation, Optimization, In Vitro, Ex Vivo, In Vivo Assessment, and Acute Toxicity Studies, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW of 25/08/2022
• what: These imperfections in the lipid matrix prevent the leakage of the drug during long-term storage and result in a higher drug . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.